Skye Bioscience, Inc. Deferred State and Local Income Tax Expense (Benefit)
Skye Bioscience, Inc. (SKYE) reported Deferred State and Local Income Tax Expense (Benefit) of -$6.56 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2021-03-02
- Skye Bioscience, Inc. deferred state and local income tax expense (benefit) for fiscal 2020 was -$6.56M, a 685.11% decline from fiscal 2019.
- Skye Bioscience, Inc. deferred state and local income tax expense (benefit) for fiscal 2019 was $1.12M.
- Skye Bioscience, Inc. deferred state and local income tax expense (benefit) for fiscal 2018 was -$19.19M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month |
|---|---|
| 2020-12-31 | -$6.56M 10-K · filed 2021-03-02 |
| 2019-12-31 | $1.12M 10-K · filed 2021-03-02 |
| 2018-12-31 | -$19.19M 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |